{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-124193","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2022-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.982978+00:00","generated_at":"2026-06-21T10:07:49.032089+00:00","sec_items":["1.01","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Cellectar adopts amended bylaws and indemnification agreements for directors and officers","bullets":["Bylaws amended to include exclusive forum provision and clarify director removal only for cause with majority vote.","Special meetings of stockholders and stockholder proposals subject to enhanced procedural mechanics.","Indemnification agreements with each director and executive officer provide full indemnity to extent permitted by Delaware law.","Company also updated bylaws to reflect current name, DGCL updates, and emergency procedures under Section 110.","No financial or operational changes reported; governance-only filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-124193","json":"https://secwatch.observer/filing/0001104659-22-124193.json","markdown":"https://secwatch.observer/filing/0001104659-22-124193.md","text":"https://secwatch.observer/filing/0001104659-22-124193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465922124193/0001104659-22-124193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465922124193/tm2231728d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T10:07:49.032089+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"eff3225405fbe16eda4c762b9ecc18305206da58","claim":"Cellectar Biosciences, Inc.: Amended and restated by-laws to reflect name change, enhance stockholder meeting mechanics, add director nomination requirements, clarify board procedures, and make other updates (effective 2022-11-29).","evidence_excerpt":"On November 29, 2022, the board of directors (the “ Board ”) of the Company adopted the Amended and Restated By-Laws of the Company (the “ By-Laws ”), effective immediately.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465922124193/0001104659-22-124193-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2022-11-29"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}